Insider Transactions in Q2 2025 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2025
|
Hannah Valantine |
SELL
Open market or private sale
|
Direct |
4,292
-70.87%
|
$171,680
$40.0 P/Share
|
|
Jun 10
2025
|
Hannah Valantine |
BUY
Exercise of conversion of derivative security
|
Direct |
4,292
+41.48%
|
$68,672
$16.75 P/Share
|
|
May 20
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
75,000
-1.54%
|
$2,475,000
$33.4 P/Share
|
|
May 19
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,156
-5.38%
|
$863,148
$33.54 P/Share
|
|
May 16
2025
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,854
-11.89%
|
$1,084,182
$33.84 P/Share
|
|
May 16
2025
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,696
+18.97%
|
-
|
|
May 16
2025
|
Maricel Apuli Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,780
-3.24%
|
$157,740
$33.84 P/Share
|
|
May 16
2025
|
Thomas Trimarchi President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,317
-4.07%
|
$703,461
$33.84 P/Share
|
|
May 12
2025
|
Kkr Genetic Disorder L.P. |
SELL
Open market or private sale
|
Indirect |
6,000,000
-31.15%
|
$204,000,000
$34.2 P/Share
|
|
May 08
2025
|
Frank Mccormick |
SELL
Bona fide gift
|
Direct |
3,000
-3.76%
|
-
|
|
May 07
2025
|
Frank Mccormick |
SELL
Bona fide gift
|
Direct |
33,000
-29.28%
|
-
|
|
May 02
2025
|
Maricel Apuli Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,026
-0.69%
|
$38,988
$38.51 P/Share
|
|
May 02
2025
|
Andrew Lo |
SELL
Open market or private sale
|
Indirect |
100,000
-48.64%
|
$3,800,000
$38.5 P/Share
|
|
Apr 22
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
75,000
-1.52%
|
$2,550,000
$34.11 P/Share
|
|
Apr 14
2025
|
Andrea Ellis |
SELL
Open market or private sale
|
Direct |
10,000
-45.45%
|
$350,000
$35.0 P/Share
|
|
Apr 14
2025
|
Andrea Ellis |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+31.25%
|
$80,000
$8.45 P/Share
|
|
Apr 01
2025
|
Andrea Ellis |
SELL
Open market or private sale
|
Direct |
30,000
-71.43%
|
$1,020,000
$34.05 P/Share
|
|
Apr 01
2025
|
Andrea Ellis |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+41.67%
|
$240,000
$8.45 P/Share
|